Project
Illumina Body Map 2, young vs old
Navigation
Downloads
Results for NR4A3
Z-value: 0.31
Motif logo
Transcription factors associated with NR4A3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
NR4A3
|
ENSG00000119508.13 | nuclear receptor subfamily 4 group A member 3 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| NR4A3 | hg19_v2_chr9_+_102584128_102584144 | -0.25 | 1.7e-01 | Click! |
Activity profile of NR4A3 motif
Sorted Z-values of NR4A3 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr17_+_4854375 | 6.66 |
ENST00000521811.1
ENST00000519602.1 ENST00000323997.6 ENST00000522249.1 ENST00000519584.1 |
ENO3
|
enolase 3 (beta, muscle) |
| chr12_-_47219733 | 6.44 |
ENST00000547477.1
ENST00000447411.1 ENST00000266579.4 |
SLC38A4
|
solute carrier family 38, member 4 |
| chr1_-_229569834 | 4.81 |
ENST00000366684.3
ENST00000366683.2 |
ACTA1
|
actin, alpha 1, skeletal muscle |
| chr16_-_31439735 | 4.68 |
ENST00000287490.4
|
COX6A2
|
cytochrome c oxidase subunit VIa polypeptide 2 |
| chrX_-_55020511 | 4.63 |
ENST00000375006.3
ENST00000374992.2 |
PFKFB1
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
| chr1_+_64059332 | 4.46 |
ENST00000540265.1
|
PGM1
|
phosphoglucomutase 1 |
| chr2_-_21266935 | 4.37 |
ENST00000233242.1
|
APOB
|
apolipoprotein B |
| chr17_+_4855053 | 4.17 |
ENST00000518175.1
|
ENO3
|
enolase 3 (beta, muscle) |
| chr1_-_120311517 | 4.15 |
ENST00000369406.3
ENST00000544913.2 |
HMGCS2
|
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
| chr11_-_73720122 | 3.89 |
ENST00000426995.2
|
UCP3
|
uncoupling protein 3 (mitochondrial, proton carrier) |
| chr19_-_4535233 | 3.83 |
ENST00000381848.3
ENST00000588887.1 ENST00000586133.1 |
PLIN5
|
perilipin 5 |
| chr19_-_45826125 | 3.79 |
ENST00000221476.3
|
CKM
|
creatine kinase, muscle |
| chr11_-_73720276 | 3.76 |
ENST00000348534.4
|
UCP3
|
uncoupling protein 3 (mitochondrial, proton carrier) |
| chr3_+_186435065 | 3.72 |
ENST00000287611.2
ENST00000265023.4 |
KNG1
|
kininogen 1 |
| chr3_+_186435137 | 3.68 |
ENST00000447445.1
|
KNG1
|
kininogen 1 |
| chr10_-_74714533 | 3.43 |
ENST00000373032.3
|
PLA2G12B
|
phospholipase A2, group XIIB |
| chr10_-_97175444 | 3.36 |
ENST00000486141.2
|
SORBS1
|
sorbin and SH3 domain containing 1 |
| chr2_-_179567206 | 3.33 |
ENST00000414766.1
|
TTN
|
titin |
| chrX_-_55024967 | 3.24 |
ENST00000545676.1
|
PFKFB1
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
| chr1_-_173886491 | 3.21 |
ENST00000367698.3
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1 |
| chr12_+_109577202 | 3.06 |
ENST00000377848.3
ENST00000377854.5 |
ACACB
|
acetyl-CoA carboxylase beta |
| chr12_-_122296755 | 3.01 |
ENST00000289004.4
|
HPD
|
4-hydroxyphenylpyruvate dioxygenase |
| chr19_+_4153598 | 3.00 |
ENST00000078445.2
ENST00000252587.3 ENST00000595923.1 ENST00000602257.1 ENST00000602147.1 |
CREB3L3
|
cAMP responsive element binding protein 3-like 3 |
| chr1_+_167063282 | 2.98 |
ENST00000361200.2
|
DUSP27
|
dual specificity phosphatase 27 (putative) |
| chr1_+_110009215 | 2.94 |
ENST00000369872.3
|
SYPL2
|
synaptophysin-like 2 |
| chr3_+_121311966 | 2.93 |
ENST00000338040.4
|
FBXO40
|
F-box protein 40 |
| chr17_+_4675175 | 2.90 |
ENST00000270560.3
|
TM4SF5
|
transmembrane 4 L six family member 5 |
| chr1_-_27240455 | 2.89 |
ENST00000254227.3
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2 |
| chr17_-_64216748 | 2.86 |
ENST00000585162.1
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
| chr2_-_31637560 | 2.79 |
ENST00000379416.3
|
XDH
|
xanthine dehydrogenase |
| chr3_+_46538981 | 2.78 |
ENST00000296142.3
|
RTP3
|
receptor (chemosensory) transporter protein 3 |
| chr12_+_57828521 | 2.65 |
ENST00000309668.2
|
INHBC
|
inhibin, beta C |
| chr12_+_81101277 | 2.62 |
ENST00000228641.3
|
MYF6
|
myogenic factor 6 (herculin) |
| chr19_-_4517613 | 2.62 |
ENST00000301286.3
|
PLIN4
|
perilipin 4 |
| chr16_-_4292071 | 2.58 |
ENST00000399609.3
|
SRL
|
sarcalumenin |
| chr11_-_57282349 | 2.54 |
ENST00000528450.1
|
SLC43A1
|
solute carrier family 43 (amino acid system L transporter), member 1 |
| chr4_+_155484155 | 2.45 |
ENST00000509493.1
|
FGB
|
fibrinogen beta chain |
| chr6_+_43265992 | 2.43 |
ENST00000449231.1
ENST00000372589.3 ENST00000372585.5 |
SLC22A7
|
solute carrier family 22 (organic anion transporter), member 7 |
| chr19_-_48867171 | 2.40 |
ENST00000377431.2
ENST00000436660.2 ENST00000541566.1 |
TMEM143
|
transmembrane protein 143 |
| chr9_-_130637244 | 2.36 |
ENST00000373156.1
|
AK1
|
adenylate kinase 1 |
| chr17_+_55173955 | 2.34 |
ENST00000576591.1
|
AKAP1
|
A kinase (PRKA) anchor protein 1 |
| chr2_+_170366203 | 2.34 |
ENST00000284669.1
|
KLHL41
|
kelch-like family member 41 |
| chr13_-_114107839 | 2.33 |
ENST00000375418.3
|
ADPRHL1
|
ADP-ribosylhydrolase like 1 |
| chr9_+_92219919 | 2.28 |
ENST00000252506.6
ENST00000375769.1 |
GADD45G
|
growth arrest and DNA-damage-inducible, gamma |
| chr1_-_20306909 | 2.27 |
ENST00000375111.3
ENST00000400520.3 |
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid) |
| chrX_-_43741594 | 2.24 |
ENST00000536181.1
ENST00000378069.4 |
MAOB
|
monoamine oxidase B |
| chr12_+_121163538 | 2.22 |
ENST00000242592.4
|
ACADS
|
acyl-CoA dehydrogenase, C-2 to C-3 short chain |
| chr8_+_11534462 | 2.22 |
ENST00000528712.1
ENST00000532977.1 |
GATA4
|
GATA binding protein 4 |
| chr2_+_120189422 | 2.22 |
ENST00000306406.4
|
TMEM37
|
transmembrane protein 37 |
| chr19_-_48867291 | 2.20 |
ENST00000435956.3
|
TMEM143
|
transmembrane protein 143 |
| chr22_+_21128167 | 2.20 |
ENST00000215727.5
|
SERPIND1
|
serpin peptidase inhibitor, clade D (heparin cofactor), member 1 |
| chr13_+_113760098 | 2.17 |
ENST00000346342.3
ENST00000541084.1 ENST00000375581.3 |
F7
|
coagulation factor VII (serum prothrombin conversion accelerator) |
| chr1_+_196857144 | 2.15 |
ENST00000367416.2
ENST00000251424.4 ENST00000367418.2 |
CFHR4
|
complement factor H-related 4 |
| chr16_+_83932684 | 2.11 |
ENST00000262430.4
|
MLYCD
|
malonyl-CoA decarboxylase |
| chr11_+_66824276 | 2.11 |
ENST00000308831.2
|
RHOD
|
ras homolog family member D |
| chr14_+_21498360 | 2.06 |
ENST00000321760.6
ENST00000460647.2 ENST00000530140.2 ENST00000472458.1 |
TPPP2
|
tubulin polymerization-promoting protein family member 2 |
| chr14_+_21498666 | 2.01 |
ENST00000481535.1
|
TPPP2
|
tubulin polymerization-promoting protein family member 2 |
| chr4_+_71494461 | 2.00 |
ENST00000396073.3
|
ENAM
|
enamelin |
| chr17_+_79679369 | 2.00 |
ENST00000350690.5
|
SLC25A10
|
solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10 |
| chr15_-_83621435 | 1.99 |
ENST00000450735.2
ENST00000426485.1 ENST00000399166.2 ENST00000304231.8 |
HOMER2
|
homer homolog 2 (Drosophila) |
| chr11_+_66824346 | 1.98 |
ENST00000532559.1
|
RHOD
|
ras homolog family member D |
| chr3_-_52860850 | 1.96 |
ENST00000441637.2
|
ITIH4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
| chr4_-_111563076 | 1.94 |
ENST00000354925.2
ENST00000511990.1 |
PITX2
|
paired-like homeodomain 2 |
| chr22_-_24110063 | 1.93 |
ENST00000520222.1
ENST00000401675.3 |
CHCHD10
|
coiled-coil-helix-coiled-coil-helix domain containing 10 |
| chr14_-_21492251 | 1.91 |
ENST00000554398.1
|
NDRG2
|
NDRG family member 2 |
| chr1_-_79472365 | 1.91 |
ENST00000370742.3
|
ELTD1
|
EGF, latrophilin and seven transmembrane domain containing 1 |
| chr15_-_75017711 | 1.91 |
ENST00000567032.1
ENST00000564596.1 ENST00000566503.1 ENST00000395049.4 ENST00000395048.2 ENST00000379727.3 |
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1 |
| chr16_+_691792 | 1.90 |
ENST00000307650.4
|
FAM195A
|
family with sequence similarity 195, member A |
| chr3_-_184095923 | 1.88 |
ENST00000445696.2
ENST00000204615.7 |
THPO
|
thrombopoietin |
| chr2_-_21266816 | 1.84 |
ENST00000399256.4
|
APOB
|
apolipoprotein B |
| chr2_+_26467825 | 1.83 |
ENST00000545822.1
ENST00000425035.1 |
HADHB
|
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit |
| chr14_+_95047744 | 1.82 |
ENST00000553511.1
ENST00000554633.1 ENST00000555681.1 ENST00000554276.1 |
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
| chr17_-_34329084 | 1.82 |
ENST00000354059.4
ENST00000536149.1 |
CCL15
CCL14
|
chemokine (C-C motif) ligand 15 chemokine (C-C motif) ligand 14 |
| chr4_+_100495864 | 1.82 |
ENST00000265517.5
ENST00000422897.2 |
MTTP
|
microsomal triglyceride transfer protein |
| chr19_+_35630628 | 1.81 |
ENST00000588715.1
ENST00000588607.1 |
FXYD1
|
FXYD domain containing ion transport regulator 1 |
| chr1_-_144994909 | 1.79 |
ENST00000369347.4
ENST00000369354.3 |
PDE4DIP
|
phosphodiesterase 4D interacting protein |
| chr10_+_101542462 | 1.77 |
ENST00000370449.4
ENST00000370434.1 |
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
| chr1_+_100111580 | 1.76 |
ENST00000605497.1
|
PALMD
|
palmdelphin |
| chr17_-_79995553 | 1.76 |
ENST00000581584.1
ENST00000577712.1 ENST00000582900.1 ENST00000579155.1 ENST00000306869.2 |
DCXR
|
dicarbonyl/L-xylulose reductase |
| chr12_+_121163602 | 1.75 |
ENST00000411593.2
|
ACADS
|
acyl-CoA dehydrogenase, C-2 to C-3 short chain |
| chr1_+_160097462 | 1.74 |
ENST00000447527.1
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
| chr2_-_179659669 | 1.74 |
ENST00000436599.1
|
TTN
|
titin |
| chr2_+_128175997 | 1.73 |
ENST00000234071.3
ENST00000429925.1 ENST00000442644.1 ENST00000453608.2 |
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa) |
| chr22_-_24384260 | 1.73 |
ENST00000248935.5
|
GSTT1
|
glutathione S-transferase theta 1 |
| chr1_+_78354243 | 1.72 |
ENST00000294624.8
|
NEXN
|
nexilin (F actin binding protein) |
| chr11_+_22696314 | 1.70 |
ENST00000532398.1
ENST00000433790.1 |
GAS2
|
growth arrest-specific 2 |
| chr16_+_72090053 | 1.70 |
ENST00000576168.2
ENST00000567185.3 ENST00000567612.2 |
HP
|
haptoglobin |
| chr3_-_42917363 | 1.67 |
ENST00000437102.1
|
CYP8B1
|
cytochrome P450, family 8, subfamily B, polypeptide 1 |
| chr4_-_111563279 | 1.66 |
ENST00000511837.1
|
PITX2
|
paired-like homeodomain 2 |
| chr20_-_62130474 | 1.64 |
ENST00000217182.3
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
| chr14_+_21492331 | 1.64 |
ENST00000533984.1
ENST00000532213.2 |
AL161668.5
|
AL161668.5 |
| chr1_-_116311402 | 1.64 |
ENST00000261448.5
|
CASQ2
|
calsequestrin 2 (cardiac muscle) |
| chr4_-_186732892 | 1.62 |
ENST00000451958.1
ENST00000439914.1 ENST00000428330.1 ENST00000429056.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr11_+_57308979 | 1.61 |
ENST00000457912.1
|
SMTNL1
|
smoothelin-like 1 |
| chr4_+_76995855 | 1.61 |
ENST00000355810.4
ENST00000349321.3 |
ART3
|
ADP-ribosyltransferase 3 |
| chr17_+_79679299 | 1.60 |
ENST00000331531.5
|
SLC25A10
|
solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10 |
| chr17_+_79761997 | 1.59 |
ENST00000400723.3
ENST00000570996.1 |
GCGR
|
glucagon receptor |
| chr4_-_54518619 | 1.59 |
ENST00000507168.1
ENST00000510143.1 |
LNX1
|
ligand of numb-protein X 1, E3 ubiquitin protein ligase |
| chr5_-_95158644 | 1.57 |
ENST00000237858.6
|
GLRX
|
glutaredoxin (thioltransferase) |
| chr14_-_94421923 | 1.57 |
ENST00000555507.1
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
| chr6_+_133561725 | 1.56 |
ENST00000452339.2
|
EYA4
|
eyes absent homolog 4 (Drosophila) |
| chr7_-_87104963 | 1.55 |
ENST00000359206.3
ENST00000358400.3 ENST00000265723.4 |
ABCB4
|
ATP-binding cassette, sub-family B (MDR/TAP), member 4 |
| chr1_+_236849754 | 1.55 |
ENST00000542672.1
ENST00000366578.4 |
ACTN2
|
actinin, alpha 2 |
| chr16_+_2076869 | 1.53 |
ENST00000424542.2
ENST00000432365.2 |
SLC9A3R2
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 |
| chr17_+_1646130 | 1.53 |
ENST00000453066.1
ENST00000324015.3 ENST00000450523.2 ENST00000453723.1 ENST00000382061.4 |
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 |
| chr1_-_116311323 | 1.52 |
ENST00000456138.2
|
CASQ2
|
calsequestrin 2 (cardiac muscle) |
| chr22_-_24384240 | 1.49 |
ENST00000439996.2
ENST00000417870.1 |
GSTT1
|
glutathione S-transferase theta 1 |
| chr11_-_74442430 | 1.49 |
ENST00000376332.3
|
CHRDL2
|
chordin-like 2 |
| chr22_+_31488433 | 1.48 |
ENST00000455608.1
|
SMTN
|
smoothelin |
| chr22_+_46546406 | 1.46 |
ENST00000440343.1
ENST00000415785.1 |
PPARA
|
peroxisome proliferator-activated receptor alpha |
| chr14_+_95048217 | 1.46 |
ENST00000557598.1
ENST00000556064.1 |
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
| chr1_-_27701307 | 1.44 |
ENST00000270879.4
ENST00000354982.2 |
FCN3
|
ficolin (collagen/fibrinogen domain containing) 3 |
| chr15_+_58724184 | 1.43 |
ENST00000433326.2
|
LIPC
|
lipase, hepatic |
| chr19_-_7293942 | 1.41 |
ENST00000341500.5
ENST00000302850.5 |
INSR
|
insulin receptor |
| chr12_+_53817633 | 1.40 |
ENST00000257863.4
ENST00000550311.1 ENST00000379791.3 |
AMHR2
|
anti-Mullerian hormone receptor, type II |
| chr13_+_24883703 | 1.39 |
ENST00000332018.4
|
C1QTNF9
|
C1q and tumor necrosis factor related protein 9 |
| chr19_-_51289436 | 1.38 |
ENST00000562076.1
|
CTD-2568A17.1
|
CTD-2568A17.1 |
| chr12_+_109592477 | 1.38 |
ENST00000544726.1
|
ACACB
|
acetyl-CoA carboxylase beta |
| chr3_-_50340996 | 1.38 |
ENST00000266031.4
ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1
|
hyaluronoglucosaminidase 1 |
| chr3_-_197300194 | 1.38 |
ENST00000358186.2
ENST00000431056.1 |
BDH1
|
3-hydroxybutyrate dehydrogenase, type 1 |
| chr1_-_2461684 | 1.37 |
ENST00000378453.3
|
HES5
|
hes family bHLH transcription factor 5 |
| chr14_-_20903801 | 1.35 |
ENST00000344581.4
|
KLHL33
|
kelch-like family member 33 |
| chr22_+_46546494 | 1.34 |
ENST00000396000.2
ENST00000262735.5 ENST00000420804.1 |
PPARA
|
peroxisome proliferator-activated receptor alpha |
| chr1_-_22222764 | 1.34 |
ENST00000439717.2
ENST00000412328.1 |
HSPG2
|
heparan sulfate proteoglycan 2 |
| chr1_-_144994840 | 1.33 |
ENST00000369351.3
ENST00000369349.3 |
PDE4DIP
|
phosphodiesterase 4D interacting protein |
| chr17_-_6616678 | 1.32 |
ENST00000381074.4
ENST00000293800.6 ENST00000572352.1 ENST00000576323.1 ENST00000573648.1 |
SLC13A5
|
solute carrier family 13 (sodium-dependent citrate transporter), member 5 |
| chr19_-_36643329 | 1.32 |
ENST00000589154.1
|
COX7A1
|
cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) |
| chr14_-_102976135 | 1.30 |
ENST00000560748.1
|
ANKRD9
|
ankyrin repeat domain 9 |
| chr12_+_16500599 | 1.30 |
ENST00000535309.1
ENST00000540056.1 ENST00000396209.1 ENST00000540126.1 |
MGST1
|
microsomal glutathione S-transferase 1 |
| chr17_-_10325261 | 1.30 |
ENST00000403437.2
|
MYH8
|
myosin, heavy chain 8, skeletal muscle, perinatal |
| chr11_+_64073699 | 1.29 |
ENST00000405666.1
ENST00000468670.1 |
ESRRA
|
estrogen-related receptor alpha |
| chr4_-_186733119 | 1.29 |
ENST00000419063.1
|
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr1_-_11107280 | 1.29 |
ENST00000400897.3
ENST00000400898.3 |
MASP2
|
mannan-binding lectin serine peptidase 2 |
| chr3_-_46000064 | 1.29 |
ENST00000433878.1
|
FYCO1
|
FYVE and coiled-coil domain containing 1 |
| chr13_-_46679144 | 1.27 |
ENST00000181383.4
|
CPB2
|
carboxypeptidase B2 (plasma) |
| chr11_+_3968573 | 1.26 |
ENST00000532990.1
|
STIM1
|
stromal interaction molecule 1 |
| chr20_-_60982330 | 1.26 |
ENST00000279101.5
|
CABLES2
|
Cdk5 and Abl enzyme substrate 2 |
| chr19_-_1513188 | 1.26 |
ENST00000330475.4
|
ADAMTSL5
|
ADAMTS-like 5 |
| chr16_-_30537839 | 1.25 |
ENST00000380412.5
|
ZNF768
|
zinc finger protein 768 |
| chr17_+_55173933 | 1.24 |
ENST00000539273.1
|
AKAP1
|
A kinase (PRKA) anchor protein 1 |
| chr15_-_76603727 | 1.24 |
ENST00000560595.1
ENST00000433983.2 ENST00000559386.1 ENST00000559602.1 ENST00000560726.1 ENST00000557943.1 |
ETFA
|
electron-transfer-flavoprotein, alpha polypeptide |
| chr18_+_11981547 | 1.24 |
ENST00000588927.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
| chr8_-_105479270 | 1.23 |
ENST00000521573.2
ENST00000351513.2 |
DPYS
|
dihydropyrimidinase |
| chr3_-_38691119 | 1.22 |
ENST00000333535.4
ENST00000413689.1 ENST00000443581.1 ENST00000425664.1 ENST00000451551.2 |
SCN5A
|
sodium channel, voltage-gated, type V, alpha subunit |
| chr3_-_46000146 | 1.22 |
ENST00000438446.1
|
FYCO1
|
FYVE and coiled-coil domain containing 1 |
| chr16_-_73082274 | 1.22 |
ENST00000268489.5
|
ZFHX3
|
zinc finger homeobox 3 |
| chr16_-_30538079 | 1.22 |
ENST00000562803.1
|
ZNF768
|
zinc finger protein 768 |
| chr13_-_46679185 | 1.22 |
ENST00000439329.3
|
CPB2
|
carboxypeptidase B2 (plasma) |
| chr14_+_74035763 | 1.22 |
ENST00000238651.5
|
ACOT2
|
acyl-CoA thioesterase 2 |
| chr22_-_51016846 | 1.20 |
ENST00000312108.7
ENST00000395650.2 |
CPT1B
|
carnitine palmitoyltransferase 1B (muscle) |
| chr15_-_99548775 | 1.19 |
ENST00000378919.6
|
PGPEP1L
|
pyroglutamyl-peptidase I-like |
| chrX_-_53461288 | 1.19 |
ENST00000375298.4
ENST00000375304.5 |
HSD17B10
|
hydroxysteroid (17-beta) dehydrogenase 10 |
| chr11_-_63993690 | 1.18 |
ENST00000394546.2
ENST00000541278.1 |
TRPT1
|
tRNA phosphotransferase 1 |
| chr1_+_222913009 | 1.17 |
ENST00000456298.1
|
FAM177B
|
family with sequence similarity 177, member B |
| chr17_-_7307358 | 1.16 |
ENST00000576017.1
ENST00000302422.3 ENST00000535512.1 |
TMEM256
TMEM256-PLSCR3
|
transmembrane protein 256 TMEM256-PLSCR3 readthrough (NMD candidate) |
| chr18_+_29077990 | 1.15 |
ENST00000261590.8
|
DSG2
|
desmoglein 2 |
| chrX_-_53461305 | 1.15 |
ENST00000168216.6
|
HSD17B10
|
hydroxysteroid (17-beta) dehydrogenase 10 |
| chr11_-_64013663 | 1.15 |
ENST00000392210.2
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
| chr12_+_53443963 | 1.15 |
ENST00000546602.1
ENST00000552570.1 ENST00000549700.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
| chr2_-_75796837 | 1.15 |
ENST00000233712.1
|
EVA1A
|
eva-1 homolog A (C. elegans) |
| chr4_-_70080449 | 1.12 |
ENST00000446444.1
|
UGT2B11
|
UDP glucuronosyltransferase 2 family, polypeptide B11 |
| chr1_+_6511651 | 1.12 |
ENST00000434576.1
|
ESPN
|
espin |
| chrX_+_135230712 | 1.11 |
ENST00000535737.1
|
FHL1
|
four and a half LIM domains 1 |
| chr18_+_18822185 | 1.11 |
ENST00000424526.1
ENST00000400483.4 ENST00000431264.1 |
GREB1L
|
growth regulation by estrogen in breast cancer-like |
| chrX_+_46937745 | 1.11 |
ENST00000397180.1
ENST00000457380.1 ENST00000352078.4 |
RGN
|
regucalcin |
| chr11_+_17741111 | 1.10 |
ENST00000250003.3
|
MYOD1
|
myogenic differentiation 1 |
| chr3_+_25831567 | 1.09 |
ENST00000280701.3
ENST00000420173.2 |
OXSM
|
3-oxoacyl-ACP synthase, mitochondrial |
| chr2_+_234686976 | 1.09 |
ENST00000389758.3
|
MROH2A
|
maestro heat-like repeat family member 2A |
| chr5_+_179233376 | 1.08 |
ENST00000376929.3
ENST00000514093.1 |
SQSTM1
|
sequestosome 1 |
| chr19_+_34891252 | 1.08 |
ENST00000606020.1
|
RP11-618P17.4
|
Uncharacterized protein |
| chr1_+_150480576 | 1.08 |
ENST00000346569.6
|
ECM1
|
extracellular matrix protein 1 |
| chr19_+_49713991 | 1.08 |
ENST00000597316.1
|
TRPM4
|
transient receptor potential cation channel, subfamily M, member 4 |
| chr3_-_145940214 | 1.07 |
ENST00000481701.1
|
PLSCR4
|
phospholipid scramblase 4 |
| chr1_-_17380630 | 1.07 |
ENST00000375499.3
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip) |
| chr1_+_78354175 | 1.06 |
ENST00000401035.3
ENST00000457030.1 ENST00000330010.8 |
NEXN
|
nexilin (F actin binding protein) |
| chr22_-_51017084 | 1.06 |
ENST00000360719.2
ENST00000457250.1 ENST00000440709.1 |
CPT1B
|
carnitine palmitoyltransferase 1B (muscle) |
| chr11_-_1783633 | 1.05 |
ENST00000367196.3
|
CTSD
|
cathepsin D |
| chr5_-_42811986 | 1.05 |
ENST00000511224.1
ENST00000507920.1 ENST00000510965.1 |
SEPP1
|
selenoprotein P, plasma, 1 |
| chr17_-_41132410 | 1.04 |
ENST00000409446.3
ENST00000453594.1 ENST00000409399.1 ENST00000421990.2 |
PTGES3L
PTGES3L-AARSD1
|
prostaglandin E synthase 3 (cytosolic)-like PTGES3L-AARSD1 readthrough |
| chr11_+_102552041 | 1.04 |
ENST00000537079.1
|
RP11-817J15.3
|
Uncharacterized protein |
| chr7_+_73868120 | 1.03 |
ENST00000265755.3
|
GTF2IRD1
|
GTF2I repeat domain containing 1 |
| chr16_+_89168753 | 1.03 |
ENST00000544543.1
|
ACSF3
|
acyl-CoA synthetase family member 3 |
| chr20_+_5987890 | 1.01 |
ENST00000378868.4
|
CRLS1
|
cardiolipin synthase 1 |
| chr4_-_48014931 | 1.01 |
ENST00000420489.2
ENST00000504722.1 |
CNGA1
|
cyclic nucleotide gated channel alpha 1 |
| chr17_+_36858694 | 1.01 |
ENST00000563897.1
|
CTB-58E17.1
|
CTB-58E17.1 |
| chr1_-_40042416 | 1.00 |
ENST00000372857.3
ENST00000372856.3 ENST00000531243.2 ENST00000451091.2 |
PABPC4
|
poly(A) binding protein, cytoplasmic 4 (inducible form) |
| chr1_-_153599426 | 1.00 |
ENST00000392622.1
|
S100A13
|
S100 calcium binding protein A13 |
| chr7_-_95025661 | 1.00 |
ENST00000542556.1
ENST00000265627.5 ENST00000427422.1 ENST00000451904.1 |
PON1
PON3
|
paraoxonase 1 paraoxonase 3 |
| chr12_+_56624436 | 1.00 |
ENST00000266980.4
ENST00000437277.1 |
SLC39A5
|
solute carrier family 39 (zinc transporter), member 5 |
| chr5_-_150466692 | 0.99 |
ENST00000315050.7
ENST00000523338.1 ENST00000522100.1 |
TNIP1
|
TNFAIP3 interacting protein 1 |
| chr1_+_53392901 | 0.98 |
ENST00000371514.3
ENST00000528311.1 ENST00000371509.4 ENST00000407246.2 ENST00000371513.5 |
SCP2
|
sterol carrier protein 2 |
| chr18_+_29078131 | 0.98 |
ENST00000585206.1
|
DSG2
|
desmoglein 2 |
| chr4_+_159593418 | 0.98 |
ENST00000507475.1
ENST00000307738.5 |
ETFDH
|
electron-transferring-flavoprotein dehydrogenase |
| chr20_+_13202418 | 0.98 |
ENST00000262487.4
|
ISM1
|
isthmin 1, angiogenesis inhibitor |
| chrX_-_128657457 | 0.98 |
ENST00000371121.3
ENST00000371123.1 ENST00000371122.4 |
SMARCA1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 |
| chr9_+_139746792 | 0.98 |
ENST00000317446.2
ENST00000445819.1 |
MAMDC4
|
MAM domain containing 4 |
| chr15_+_63050785 | 0.98 |
ENST00000472902.1
|
TLN2
|
talin 2 |
| chr1_+_171283331 | 0.97 |
ENST00000367749.3
|
FMO4
|
flavin containing monooxygenase 4 |
| chr11_+_65292884 | 0.97 |
ENST00000527009.1
|
SCYL1
|
SCY1-like 1 (S. cerevisiae) |
| chr17_-_2615031 | 0.96 |
ENST00000576885.1
ENST00000574426.2 |
CLUH
|
clustered mitochondria (cluA/CLU1) homolog |
Network of associatons between targets according to the STRING database.
First level regulatory network of NR4A3
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 3.8 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 1.2 | 3.6 | GO:0015743 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 1.1 | 7.9 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.9 | 8.5 | GO:0010269 | response to selenium ion(GO:0010269) |
| 0.9 | 6.6 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
| 0.9 | 2.8 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 0.9 | 0.9 | GO:0006154 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
| 0.8 | 4.8 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.8 | 2.4 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 0.7 | 5.1 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.7 | 3.6 | GO:0060127 | subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) superior vena cava morphogenesis(GO:0060578) |
| 0.7 | 2.8 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.7 | 2.0 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.7 | 2.0 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
| 0.6 | 1.9 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 0.6 | 1.9 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.6 | 3.6 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.6 | 1.8 | GO:0050787 | antibiotic metabolic process(GO:0016999) detoxification of mercury ion(GO:0050787) |
| 0.6 | 1.8 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.6 | 2.9 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.6 | 1.7 | GO:1903280 | negative regulation of calcium:sodium antiporter activity(GO:1903280) |
| 0.6 | 2.9 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.6 | 4.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.6 | 1.7 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 0.6 | 2.2 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.5 | 14.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.5 | 2.3 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.5 | 1.4 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) negative regulation of pro-B cell differentiation(GO:2000974) |
| 0.4 | 1.3 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.4 | 1.7 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.4 | 1.3 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
| 0.4 | 2.1 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
| 0.4 | 5.5 | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 0.4 | 1.5 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.4 | 1.9 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.4 | 1.1 | GO:0014908 | myoblast fate determination(GO:0007518) myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
| 0.3 | 1.4 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 0.3 | 2.4 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.3 | 3.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.3 | 2.3 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.3 | 3.2 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.3 | 2.2 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.3 | 7.1 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
| 0.3 | 5.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.3 | 1.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 0.3 | 0.9 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.3 | 0.9 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
| 0.3 | 0.9 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.3 | 0.9 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
| 0.3 | 2.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.3 | 0.9 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
| 0.3 | 0.9 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.3 | 1.4 | GO:1990535 | neuron projection maintenance(GO:1990535) |
| 0.3 | 0.8 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.3 | 0.8 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.3 | 1.1 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
| 0.3 | 1.0 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 0.3 | 1.0 | GO:0035565 | regulation of pronephros size(GO:0035565) |
| 0.3 | 1.0 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) phenylpropanoid catabolic process(GO:0046271) |
| 0.2 | 1.0 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.2 | 1.7 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.2 | 4.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.2 | 0.7 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.2 | 4.0 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
| 0.2 | 1.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.2 | 13.4 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.2 | 0.7 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.2 | 0.7 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.2 | 1.8 | GO:0010731 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.2 | 2.7 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.2 | 1.0 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.2 | 0.8 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.2 | 2.4 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.2 | 3.6 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.2 | 0.6 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.2 | 5.4 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.2 | 2.5 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.2 | 1.0 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.2 | 0.6 | GO:0015881 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.2 | 0.4 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.2 | 0.6 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.2 | 0.7 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.2 | 1.8 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.2 | 1.1 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.2 | 1.3 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.2 | 0.7 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.2 | 0.9 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.2 | 0.7 | GO:0060694 | regulation of cholesterol transporter activity(GO:0060694) response to metformin(GO:1901558) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.2 | 2.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.2 | 2.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.2 | 2.7 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.2 | 0.8 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.2 | 0.6 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.2 | 2.0 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
| 0.1 | 1.0 | GO:0097068 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 0.1 | 1.0 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 | 0.6 | GO:0002035 | brain renin-angiotensin system(GO:0002035) angiotensin-mediated drinking behavior(GO:0003051) |
| 0.1 | 1.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.1 | 1.5 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.1 | 0.8 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.1 | 2.5 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.1 | 0.8 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.1 | 0.8 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.1 | 1.0 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
| 0.1 | 0.6 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 0.1 | 0.1 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 0.1 | 0.9 | GO:0008295 | spermidine biosynthetic process(GO:0008295) primary amino compound biosynthetic process(GO:1901162) |
| 0.1 | 0.6 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
| 0.1 | 1.0 | GO:0044211 | CTP salvage(GO:0044211) |
| 0.1 | 4.4 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.1 | 1.9 | GO:0036376 | sodium ion export from cell(GO:0036376) |
| 0.1 | 1.9 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.1 | 0.4 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 0.1 | 1.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
| 0.1 | 3.5 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.1 | 0.8 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.1 | 0.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 | 0.7 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.1 | 0.8 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 | 0.4 | GO:0090299 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.1 | 2.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 | 0.3 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 0.1 | 0.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 0.7 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.1 | 0.7 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.1 | 0.8 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.1 | 2.4 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.1 | 3.1 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.1 | 1.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.1 | 0.4 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.1 | 0.9 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.1 | 0.9 | GO:0070836 | caveola assembly(GO:0070836) |
| 0.1 | 0.9 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.1 | 0.3 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
| 0.1 | 2.9 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 | 1.6 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
| 0.1 | 1.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 1.0 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.1 | 3.6 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.1 | 0.9 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 | 3.4 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 | 0.7 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 0.1 | 0.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 0.3 | GO:1902304 | activation of blood coagulation via clotting cascade(GO:0002543) phosphatidylserine exposure on blood platelet(GO:0097045) positive regulation of potassium ion export(GO:1902304) |
| 0.1 | 1.6 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.1 | 0.7 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.1 | 0.9 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.1 | 0.2 | GO:0070781 | arginine biosynthetic process via ornithine(GO:0042450) response to biotin(GO:0070781) |
| 0.1 | 1.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 | 1.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.1 | 0.4 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.1 | 0.7 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.1 | 1.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 | 0.4 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.1 | 3.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.1 | 0.6 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 | 0.3 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
| 0.1 | 1.2 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.1 | 8.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
| 0.1 | 1.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.1 | 0.6 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.1 | 0.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 | 0.6 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 | 0.4 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.1 | 0.2 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.1 | 1.0 | GO:0042737 | drug catabolic process(GO:0042737) |
| 0.1 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) positive regulation of protein autoubiquitination(GO:1902499) |
| 0.1 | 1.5 | GO:0001503 | ossification(GO:0001503) |
| 0.1 | 5.4 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 | 3.6 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.1 | 0.3 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 | 1.8 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
| 0.1 | 0.3 | GO:0060301 | vestibulocochlear nerve structural organization(GO:0021649) neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) positive regulation of retinal ganglion cell axon guidance(GO:1902336) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.1 | 0.3 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.1 | 3.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.1 | 1.9 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
| 0.1 | 0.6 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 | 0.5 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.0 | 0.2 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.0 | 0.2 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.0 | 0.7 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.0 | 0.4 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.0 | 1.7 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.0 | 0.4 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.0 | 2.9 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.0 | 0.9 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.0 | 2.2 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
| 0.0 | 0.5 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.0 | 0.1 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.0 | 0.2 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
| 0.0 | 0.2 | GO:1902775 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 | 0.2 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.0 | 0.3 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.0 | 0.3 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.0 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.0 | 0.2 | GO:0032048 | cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) |
| 0.0 | 2.2 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.0 | 0.6 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.0 | 1.6 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.0 | 1.7 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.0 | 1.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.0 | 0.2 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.0 | 1.1 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 | 0.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 | 0.4 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.0 | 0.4 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.0 | 0.1 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.0 | 0.1 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.0 | 0.7 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 0.0 | 3.4 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 | 2.2 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.0 | 1.1 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 0.0 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.0 | 0.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.0 | 0.2 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 0.0 | 0.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.0 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 | 1.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.0 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.0 | 3.4 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.0 | 0.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
| 0.0 | 0.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.0 | 0.4 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.0 | 0.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
| 0.0 | 0.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.0 | 2.3 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.0 | 0.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.0 | 0.3 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 | 1.3 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.0 | 0.2 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.0 | 0.2 | GO:0035434 | copper ion import(GO:0015677) copper ion transmembrane transport(GO:0035434) |
| 0.0 | 0.6 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.0 | 0.3 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.0 | 0.3 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
| 0.0 | 3.2 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.0 | 0.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.0 | 0.5 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.0 | 0.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 | 0.8 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.0 | 0.1 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.0 | 0.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
| 0.0 | 0.4 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
| 0.0 | 0.6 | GO:0046688 | response to copper ion(GO:0046688) |
| 0.0 | 2.0 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
| 0.0 | 0.5 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 | 0.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 0.0 | 1.3 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.0 | 0.4 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.0 | 0.3 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.0 | 0.4 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.0 | 0.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 | 0.3 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
| 0.0 | 0.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 | 0.3 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.0 | 0.1 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.0 | 0.3 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
| 0.0 | 0.3 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
| 0.0 | 0.4 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.0 | 0.2 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.0 | 1.1 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
| 0.0 | 0.3 | GO:0002158 | osteoclast proliferation(GO:0002158) |
| 0.0 | 0.7 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.0 | 0.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.0 | 0.2 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.0 | 1.3 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
| 0.0 | 0.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 | 0.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.0 | 0.2 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.0 | 0.4 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.0 | 0.6 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
| 0.0 | 1.2 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
| 0.0 | 0.4 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.0 | 0.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.0 | 0.3 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.0 | 0.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.0 | 0.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.0 | 0.3 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.0 | 0.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.0 | 0.1 | GO:0045914 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.0 | 0.3 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 | 0.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.0 | 0.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.0 | 0.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) striatum development(GO:0021756) |
| 0.0 | 0.2 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 | 0.7 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
| 0.0 | 0.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
| 0.0 | 0.4 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.0 | 0.1 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.0 | 0.3 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 | 0.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 | 0.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.0 | 0.0 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.0 | 0.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 | 0.1 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.0 | 0.3 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
| 0.0 | 1.2 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 10.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.8 | 3.3 | GO:0036028 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 0.7 | 6.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 0.7 | 4.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.5 | 2.0 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.4 | 1.7 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 0.4 | 6.3 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.3 | 5.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.3 | 2.3 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.3 | 0.9 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.3 | 4.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.3 | 3.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.3 | 1.1 | GO:0044753 | amphisome(GO:0044753) |
| 0.3 | 4.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.2 | 0.6 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.2 | 5.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.2 | 3.1 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.2 | 0.7 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
| 0.2 | 1.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.2 | 0.8 | GO:0005606 | laminin-1 complex(GO:0005606) laminin-11 complex(GO:0043260) |
| 0.1 | 0.7 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 0.1 | 6.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.1 | 1.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.1 | 1.6 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.1 | 1.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.1 | 0.4 | GO:0036457 | keratohyalin granule(GO:0036457) |
| 0.1 | 0.3 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
| 0.1 | 3.9 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.1 | 2.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.1 | 2.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 2.1 | GO:0012505 | endomembrane system(GO:0012505) |
| 0.1 | 2.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.1 | 5.8 | GO:0005865 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
| 0.1 | 0.7 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 0.1 | 1.0 | GO:0016589 | NURF complex(GO:0016589) |
| 0.1 | 2.9 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.1 | 1.6 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.1 | 0.3 | GO:0002133 | polycystin complex(GO:0002133) |
| 0.1 | 0.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.1 | 0.2 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.1 | 1.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.1 | 1.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.1 | 0.7 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.1 | 0.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.1 | 7.1 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 2.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 0.3 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.1 | 0.8 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.1 | 2.3 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.1 | 0.8 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.1 | 1.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.1 | 0.2 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.1 | 0.2 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.1 | 6.5 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 0.6 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.1 | 37.5 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.1 | 0.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.1 | 0.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 0.8 | GO:0045179 | apical cortex(GO:0045179) |
| 0.0 | 2.0 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 22.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 0.3 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.0 | 0.6 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.0 | 1.6 | GO:0031430 | M band(GO:0031430) |
| 0.0 | 0.7 | GO:0098798 | mitochondrial protein complex(GO:0098798) |
| 0.0 | 0.6 | GO:0030478 | actin cap(GO:0030478) |
| 0.0 | 3.5 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.6 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.0 | 2.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.0 | 0.9 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.0 | 1.0 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.0 | 0.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.0 | 2.5 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.0 | 0.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 8.4 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.0 | 0.8 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.0 | 0.1 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 0.0 | 6.4 | GO:0030018 | Z disc(GO:0030018) |
| 0.0 | 0.9 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.0 | 13.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 1.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.0 | 0.7 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.0 | 0.5 | GO:0005883 | neurofilament(GO:0005883) |
| 0.0 | 0.6 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.0 | 0.4 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.0 | 0.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.0 | 0.4 | GO:0032797 | SMN complex(GO:0032797) |
| 0.0 | 1.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.0 | 0.5 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.0 | 1.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.0 | 0.5 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) microbody part(GO:0044438) peroxisomal part(GO:0044439) |
| 0.0 | 1.0 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.0 | 5.6 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.0 | 0.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.0 | 2.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.0 | 0.4 | GO:0008091 | spectrin(GO:0008091) |
| 0.0 | 2.0 | GO:0005901 | caveola(GO:0005901) |
| 0.0 | 0.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.0 | 0.8 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.0 | 0.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.0 | 2.1 | GO:0005604 | basement membrane(GO:0005604) |
| 0.0 | 0.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.0 | 0.3 | GO:0035859 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
| 0.0 | 0.2 | GO:0000801 | central element(GO:0000801) |
| 0.0 | 0.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.0 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.0 | 6.1 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.0 | 0.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 1.5 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 1.0 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.0 | 0.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 0.3 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.0 | 0.7 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 0.5 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
| 0.0 | 0.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.0 | 2.7 | GO:0061695 | transferase complex, transferring phosphorus-containing groups(GO:0061695) |
| 0.0 | 0.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.0 | 0.9 | GO:0045095 | keratin filament(GO:0045095) |
| 0.0 | 0.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 11.3 | GO:0005739 | mitochondrion(GO:0005739) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.6 | 7.9 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 1.4 | 4.1 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 1.3 | 10.0 | GO:0035473 | lipase binding(GO:0035473) |
| 1.2 | 10.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 1.2 | 3.6 | GO:0015131 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
| 1.0 | 7.1 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.8 | 1.5 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.7 | 4.4 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.7 | 2.0 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.6 | 4.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.6 | 2.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.5 | 2.3 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.4 | 1.3 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
| 0.4 | 1.3 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 0.4 | 2.8 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.4 | 5.0 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.4 | 1.9 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.4 | 1.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.4 | 1.1 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.4 | 1.4 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 0.3 | 1.4 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.3 | 2.4 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.3 | 1.0 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity(GO:0043337) |
| 0.3 | 5.1 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.3 | 1.0 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.3 | 1.0 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 0.3 | 1.0 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.3 | 3.3 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.3 | 1.0 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.3 | 1.3 | GO:0001855 | complement component C4b binding(GO:0001855) |
| 0.3 | 2.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
| 0.3 | 2.8 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.3 | 1.2 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 0.3 | 1.8 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 0.3 | 0.9 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
| 0.3 | 3.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.3 | 0.9 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.3 | 0.8 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 0.3 | 1.0 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
| 0.3 | 2.0 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 0.2 | 2.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.2 | 3.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.2 | 1.2 | GO:0002054 | nucleobase binding(GO:0002054) dihydropyrimidinase activity(GO:0004157) |
| 0.2 | 1.2 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.2 | 1.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.2 | 1.3 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
| 0.2 | 1.1 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
| 0.2 | 2.8 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.2 | 0.6 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.2 | 1.9 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.2 | 0.8 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.2 | 0.8 | GO:0002134 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
| 0.2 | 6.7 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.2 | 0.6 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
| 0.2 | 0.9 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.2 | 0.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.2 | 0.8 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.2 | 5.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.2 | 1.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.2 | 2.9 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.2 | 0.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.2 | 2.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.2 | 4.0 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.2 | 3.7 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.2 | 2.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
| 0.1 | 3.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.1 | 0.4 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 0.1 | 1.2 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.1 | 1.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.1 | 0.4 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.1 | 2.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 0.4 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
| 0.1 | 0.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.1 | 0.3 | GO:0016503 | pheromone receptor activity(GO:0016503) |
| 0.1 | 1.0 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.1 | 3.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 0.7 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.1 | 1.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.1 | 0.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.1 | 1.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.1 | 0.5 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.1 | 0.9 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.1 | 0.3 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
| 0.1 | 0.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.1 | 1.8 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.1 | 1.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.1 | 0.3 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.1 | 0.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.1 | 0.8 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.1 | 3.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 1.8 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.1 | 3.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.1 | 0.9 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
| 0.1 | 1.0 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.1 | 0.3 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.1 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.1 | 1.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.1 | 0.7 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.1 | 9.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 3.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
| 0.1 | 1.0 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.1 | 0.6 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.1 | 0.6 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
| 0.1 | 0.6 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.1 | 0.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.1 | 4.9 | GO:0043531 | ADP binding(GO:0043531) |
| 0.1 | 0.9 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.1 | 0.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.1 | 0.4 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.1 | 0.6 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.1 | 0.7 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
| 0.1 | 0.2 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
| 0.1 | 3.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.1 | 0.3 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.1 | 1.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.1 | 1.7 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
| 0.1 | 2.4 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.1 | 9.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 8.9 | GO:0005179 | hormone activity(GO:0005179) |
| 0.1 | 0.4 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.1 | 8.3 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
| 0.1 | 2.8 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.1 | 0.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.1 | 0.9 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.1 | 0.7 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 0.1 | 3.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.1 | 0.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.1 | 3.7 | GO:0070888 | E-box binding(GO:0070888) |
| 0.1 | 3.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.1 | 0.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.1 | 0.8 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 0.0 | 4.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 0.0 | 0.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 0.0 | 5.0 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.0 | 1.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.0 | 0.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.0 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.0 | 0.3 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.0 | 2.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
| 0.0 | 1.7 | GO:0030553 | cGMP binding(GO:0030553) |
| 0.0 | 2.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.0 | 1.7 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.0 | 0.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
| 0.0 | 0.5 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.0 | 1.6 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
| 0.0 | 0.3 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.0 | 2.1 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.0 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.0 | 0.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.0 | 0.2 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.0 | 0.8 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.0 | 0.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.0 | 2.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.0 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.0 | 0.3 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.0 | 0.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.0 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.0 | 1.1 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.0 | 2.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.0 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.0 | 1.8 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
| 0.0 | 0.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.0 | 1.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.0 | 0.2 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.0 | 1.2 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.0 | 2.3 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.0 | 3.4 | GO:0051087 | chaperone binding(GO:0051087) |
| 0.0 | 0.4 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
| 0.0 | 0.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.0 | 0.1 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.0 | 0.2 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
| 0.0 | 0.1 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) linoleoyl-CoA desaturase activity(GO:0016213) 5'-flap endonuclease activity(GO:0017108) |
| 0.0 | 0.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.0 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.0 | 2.1 | GO:0005319 | lipid transporter activity(GO:0005319) |
| 0.0 | 0.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.0 | 2.0 | GO:0019003 | GDP binding(GO:0019003) |
| 0.0 | 0.2 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.0 | 0.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.0 | 1.1 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.0 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.0 | 1.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.3 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.0 | 1.0 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.0 | 0.8 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.0 | 0.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.0 | 0.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.0 | 1.6 | GO:0005496 | steroid binding(GO:0005496) |
| 0.0 | 0.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.0 | 1.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.0 | 1.5 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
| 0.0 | 1.3 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
| 0.0 | 2.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.0 | 1.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.0 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.0 | 0.4 | GO:0008374 | O-acyltransferase activity(GO:0008374) |
| 0.0 | 1.0 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 0.0 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.0 | 0.5 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
| 0.0 | 0.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.0 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.0 | 0.6 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
| 0.0 | 0.1 | GO:0008097 | 5S rRNA binding(GO:0008097) ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.0 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.0 | 0.4 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
| 0.0 | 0.2 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.0 | 0.7 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.0 | 0.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.0 | 3.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.0 | 0.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.0 | 0.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.0 | 0.2 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.0 | 0.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.0 | 0.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.0 | 1.5 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.0 | 1.6 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.0 | 0.4 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
| 0.0 | 0.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.0 | 0.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.0 | 0.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.0 | 3.6 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.2 | 11.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.1 | 2.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.1 | 2.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 7.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 3.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 1.0 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.1 | 1.4 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.1 | 1.8 | ST ADRENERGIC | Adrenergic Pathway |
| 0.1 | 0.3 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.1 | 3.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 4.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 4.8 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.0 | 18.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.0 | 4.7 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.0 | 2.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 0.0 | 2.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.0 | 3.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.0 | 4.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 6.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 1.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.0 | 0.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.0 | 4.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.0 | 1.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.0 | 3.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.0 | 1.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.0 | 0.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.0 | 1.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.0 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.0 | 1.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.0 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.0 | 0.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.0 | 1.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 0.4 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 1.0 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.0 | 0.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 0.8 | PID P53 REGULATION PATHWAY | p53 pathway |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 10.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.3 | 17.7 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.3 | 18.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.3 | 5.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.3 | 3.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.2 | 4.0 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.2 | 2.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.2 | 7.0 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.2 | 1.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.1 | 17.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.1 | 2.8 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.1 | 9.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.1 | 3.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 5.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.1 | 3.9 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.1 | 1.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.1 | 2.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.1 | 1.5 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.1 | 1.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.1 | 2.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.1 | 2.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 2.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.1 | 0.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.1 | 1.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.1 | 4.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.1 | 4.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 7.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 2.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.1 | 1.1 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.1 | 1.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.1 | 1.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.0 | 2.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.0 | 3.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 1.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.0 | 1.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.0 | 0.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.0 | 2.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 0.2 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
| 0.0 | 1.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.0 | 1.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.0 | 2.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.0 | 1.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.0 | 1.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.0 | 5.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.0 | 1.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.0 | 0.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.0 | 1.0 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.0 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.0 | 2.4 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.0 | 1.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.0 | 0.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.0 | 1.0 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.0 | 1.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.0 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.0 | 0.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.0 | 6.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.0 | 0.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.0 | 0.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.0 | 1.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.0 | 0.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.0 | 0.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.0 | 1.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 0.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.0 | 0.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.0 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.0 | 0.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.0 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.0 | 0.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.0 | 0.6 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.0 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.0 | 1.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 0.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.0 | 2.4 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.0 | 0.3 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.0 | 0.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.0 | 0.6 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.0 | 0.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 2.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 0.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |